MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia"

  • 2025 International Congress

    Cognitive Decline in Parkinson’s Disease: A Decade-Long Registry Analysis of Prevalence and Risk Factors

    L. Ge, K. Asai, K. Ogawa, K. Ikenaka, Y. Kimura, H. Mochizuki (Suita, Japan)

    Objective: This study aims to identify predictors of cognitive decline in cognitively normal Parkinson’s disease patients by analyzing the 10 years-long PD registry. Background: Cognitive…
  • 2024 International Congress

    Association Between DPP-4 Inhibitors Use and Risk of Dementia: A Meta-analysis Using Real-world Data

    S. Hussain (New Delhi, India)

    Objective: To investigate the potential association between the use of DPP-4 inhibitors and the risk of dementia, utilizing real-world data from diverse sources. Background: Evidence…
  • 2024 International Congress

    Neuropsychological Predictors of Cognitive Decline in Parkinson’s Disease: A Systematic Review (PDCogniCare)

    D. Pourzinal, K. Sivakumaran, J. Yang, D. Bailey, L. Mitchell, D. Brooks, A. Lehn, J. Liddle, N. Pachana, H. Tinson, K. Shrubsole, N. Dissanayaka (Herston, Australia)

    Objective: This systematic review aimed to synthesise current neuropsychological predictors of cognitive decline in Parkinson's disease (PD). Background: The observed heterogeneity of cognitive function in…
  • 2024 International Congress

    Mixed Brain Pathology in Neurodegenerative Parkinsonism and Dementia

    K. Mensikova, L. Tuckova, D. Hrabos, A. Jawad, P. Kanovsky (Olomouc, Czech Republic)

    Objective: To assess the presence of mixed neurodegenerative pathology and its proportion in the prospective cohort of patients treated for any phenotype of neurodegenerative parkinsonism,…
  • 2024 International Congress

    Prodromal RBD and the risk of cognitive impairment in Parkinson’s disease.

    A. Martinez-Nunez, H. Hutchinson, V. Lavu, Q. Yuan, J. Dwarampudi, J. Wong (Gainesvile, USA)

    Objective: To identify the impact of prodromal RBD in the incidence of cognitive impairment in patients with early PD. Background: The association between sleep disorders…
  • 2024 International Congress

    The course of cognitive impairment in Parkinson’s disease patients with Сovid-19

    R. Matmurodov, B. Muminov, K. Khalimova (Tashkent, Uzbekistan)

    Objective: A comparative analysis of the characteristics of cognitive impairment in Parkinson's disease patients with and without Сovid-19. Background: Covid-19 infection strongly affects the central…
  • 2024 International Congress

    Gender-related Cognitive Disparities in Hispanic Patients with Parkinson’s Disease: A Cross-Sectional Study

    D. Piana-Castillo, C. Rodriguez-Alarcon, G. Faggioni-Sanchez, D. Bustamante-Mieles, C. Cevallos-Velasco, M. Barreiro-Guillén, R. Santibanez-Vasquez (Guayaquil, Ecuador)

    Objective: Investigate potential gender-based cognitive performance disparities within the Hispanic population diagnosed with Parkinson's disease (PD). Background: PD significantly impairs cognitive functions, adversely affecting the…
  • 2024 International Congress

    Exploring the Prevalence of Subjective Cognitive Decline and Mild Cognitive Impairment in Participants of the Luxembourg Healthy Ageing Study

    S. Jónsdóttir, C. Pauly, V. Schröder, O. Tsurkalenko, T. Marques, C. Horlings, A. Garrido, C. Vega, S. Schade, P. Mahlknecht, C. Gomes, S. Ghosh, K. Rege, R. Rawal, D. Mcintyre, K. Seppi, M. Martí, C. Trenkwalder, E. Tolosa, W. Poewe, V. Satagopam, B. Mollenhauer, R. Krüger (Heisdorf, Luxembourg)

    Objective: Determine prevalence of Subjective Cognitive Decline(SCD) and Mild Cognitive Impairment(MCI) in participants of the Luxembourg Healthy Ageing(HeBA) Study. Background: Cognitive impairment can present as…
  • 2024 International Congress

    Incidence and Prevalence of Parkinson’s Disease Among United States Medicare Beneficiaries by Age, Sex, Race/Ethnicity, and Neighborhood Socioeconomic Status 2014-2021

    T. Rosa, S. Mantri, C. Ford, S. Soneji, B. Kaufman, F. Li, B. Grory, Y. Xian, K. Johnson, R. O’Brien, E. O’Brien, J. Lusk, B. Hammill (Durham, USA)

    Objective: To evaluate the trends and differences in incidence and prevalence of Parkison's disease (PD) in Medicare beneficiaries between 2014-2021 across different demographics. Background: The…
  • 2024 International Congress

    Managing Cognitive Decline in Vascular Dementia with Associated Parkinsonism

    J. Hall, R. Islam, C. Rowan, B. Carr (GAINESVILLE, USA)

    Objective: The intersection of vascular dementia (VaD) and secondary parkinsonism presents a complex therapeutic conundrum, particularly in geriatric populations. This study aims to elucidate the…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley